Sign in
CNTB Stock Price, Chart, Stats & News
Connect Biopharma Holdings Limited
Save
Connect Biopharma Holdings Limited (CNTB) does not currently pay a dividend.
69.26M
Market cap
–
Current P/E
0.77x
Forward P/E
CNTB chart
Fundamentals
Gross margin | 90.64% |
Operating margin | -1955.53% |
Pretax margin | -1831.49% |
Net margin | -1842.59% |
Effective tax rate | -0.61% |
ROA | -43.66% |
ROE | -44.18% |
D/E | 0.01x |
Interest coverage ratio | – |
CNTB valuation
P/E | – |
P/S | 98.40x |
P/B | 2.68x |
P/CF | -6.80x |
P/FCF | -6.70x |
P/OCF | -6.80x |
PEG | 0.04x |
EV multiple | -6.44x |
About
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody.
Similar securities
Based on sector and market capitalization
Report issue